Quality investing focuses on companies with durable competitive advantages, strong and improving profitability, and solid financial health. The Caviar Cruise stock screener is designed to identify such companies by applying a rigorous set of quantifiable filters. These filters look for consistent revenue and earnings growth, high returns on invested capital, manageable debt levels, and a strong ability to convert profits into actual cash. By systematically screening for these traits, investors can narrow down the universe of stocks to those most likely to compound value over the long term. One company that emerges from this screen is Xylem Inc. (NYSE:XYL), a global water technology provider.
How Xylem Measures Up: Key Metrics from the Caviar Cruise Screen
To qualify as a potential quality investment, a stock must pass several core tests. Xylem not only meets them but in many cases exceeds the thresholds by a wide margin.
-
Revenue and Earnings Growth: The screen requires a 5-year CAGR of at least 5% for both revenue and EBIT. Xylem’s 5-year revenue CAGR is 5.28%, just clearing the bar. More impressively, its EBIT growth over the same period is 21.54% annually. This significant outperformance of revenue growth by EBIT is a key indicator of improving profitability, suggesting economies of scale or strong pricing power—both hallmarks of a quality business.
-
Return on Invested Capital (ROIC): The screen demands a ROIC (excluding cash, goodwill, and intangibles) of at least 15%. Xylem’s ROICexcg stands at a remarkable 37.94%. This is a very strong figure, indicating that the company is exceptionally efficient at allocating capital and generating profits from its core operations. A high and sustainable ROIC is the single most important metric for quality investors, as it signals a strong competitive moat.
-
Debt Management: The filter requires a Debt-to-Free Cash Flow ratio of less than 5. Xylem’s ratio is a conservative 2.13. This means the company could theoretically pay off all its debt with just over two years of its current free cash flow, reflecting a very healthy balance sheet and low financial risk.
-
Profit Quality: The screen looks for an average profit quality (free cash flow as a percentage of net income) of at least 75% over the last five years. Xylem achieves a stellar 95.05% in this metric. This confirms that the vast majority of its reported earnings are being translated into actual, hard cash, a sign of genuine profitability rather than accounting adjustments.
Each of these criteria is central to the Caviar Cruise methodology. The combination of solid growth, exceptional capital efficiency, low leverage, and high-quality earnings provides a solid foundation for a long-term buy-and-hold investment.
General Fundamental Health and Valuation
A broader look at Xylem’s fundamentals, as detailed in the full fundamental analysis report, confirms its quality profile but also highlights some points for consideration. The company receives an overall fundamental rating of 6 out of 10.
-
Profitability (Rating: 7/10): This is a clear strength. Profitability ratios like Return on Assets, Return on Equity, and various profit margins are all above the average of its industry peers in the Machinery sector.
-
Dividend (Rating: 7/10): Xylem offers a dividend yield of 1.46%, which is attractive relative to its industry. It has a long and consistent history of paying and increasing its dividend, making it a candidate for dividend growth investors.
-
Health (Rating: 6/10): The balance sheet is generally solid, with a strong Altman-Z score and excellent solvency ratios. However, the report notes that its Return on Invested Capital (ROIC) is currently below its Weighted Average Cost of Capital (WACC), suggesting a period of value destruction. Additionally, the number of shares outstanding has increased over the past year and five years, which is a negative signal.
-
Growth (Rating: 5/10): Past growth is strong, but the future outlook shows a deceleration. While EPS is expected to grow at nearly 10% annually, the growth rate is projected to slow compared to the recent past. Revenue growth expectations are more modest at around 5% per year.
-
Valuation (Rating: 3/10): This is the weakest area. With a Price/Earnings (P/E) ratio of 21.67, the stock is not cheap. While it is slightly less expensive than its industry peers, the PEG ratio suggests the current price is not fully justified by the expected growth rate. Quality investors are often willing to pay a premium for quality, but this metric serves as a cautionary note that the market already has high expectations.
Analyst Views and Market Context
While the fundamental data is solid, it’s also useful to consider the broader market environment. The current long-term trend for the S&P 500 is neutral, but the short-term trend is positive. This mixed backdrop does not directly impact a company’s quality, but it does influence the general sentiment for risk assets like equities.
For a stock like Xylem, the primary risk is not business failure but its current valuation. The high P/E ratio leaves little room for error and makes the stock more vulnerable to market corrections. Should the company fail to meet its growth expectations, the share price could face significant headwinds. The deceleration in growth, combined with the premium price tag, means the investment thesis relies heavily on the company’s ability to sustain its competitive advantages and execute its strategy flawlessly.
The Bottom Line for Quality Investors
Xylem (XYL) passes the majority of strict quality investing filters with flying colors. Its extremely high ROIC, strong profit quality, and low debt levels are textbook examples of a durable business. The company’s essential role in the global water industry provides a long-term structural growth driver.
However, the premium valuation and the slight deceleration in expected growth mean it is not a "value" play. For a quality investor following a buy-and-hold strategy, Xylem appears to be a well-run company that could be a candidate for a long-term portfolio—provided the investor is comfortable paying a fair price for that quality.
Explore More Potential Quality Stocks
The Caviar Cruise screen is a valuable tool for identifying companies with these exact characteristics. If you are interested in finding other stocks that meet these strict quality criteria, you can run the screen for yourself.
Click here to see the latest results from the Caviar Cruise stock screener
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Past performance and screening results are not guarantees of future results. Always conduct your own due diligence before making any investment decisions.
Read full article here »
View the Zacks #1 Rank List
Xylem Inc. (NYSE:XYL): A Quality Investing Pick with Strong Fundamentals and Premium Valuation
Quality investing focuses on companies with durable competitive advantages, strong and improving profitability, and solid financial health. The Caviar Cruise stock screener is designed to identify such companies by applying a rigorous set of quantifiable filters. These filters look for consistent revenue and earnings growth, high returns on invested capital, manageable debt levels, and a strong ability to convert profits into actual cash. By systematically screening for these traits, investors can narrow down the universe of stocks to those most likely to compound value over the long term. One company that emerges from this screen is Xylem Inc. (NYSE:XYL), a global water technology provider.
How Xylem Measures Up: Key Metrics from the Caviar Cruise Screen
To qualify as a potential quality investment, a stock must pass several core tests. Xylem not only meets them but in many cases exceeds the thresholds by a wide margin.
Revenue and Earnings Growth: The screen requires a 5-year CAGR of at least 5% for both revenue and EBIT. Xylem’s 5-year revenue CAGR is 5.28%, just clearing the bar. More impressively, its EBIT growth over the same period is 21.54% annually. This significant outperformance of revenue growth by EBIT is a key indicator of improving profitability, suggesting economies of scale or strong pricing power—both hallmarks of a quality business.
Return on Invested Capital (ROIC): The screen demands a ROIC (excluding cash, goodwill, and intangibles) of at least 15%. Xylem’s ROICexcg stands at a remarkable 37.94%. This is a very strong figure, indicating that the company is exceptionally efficient at allocating capital and generating profits from its core operations. A high and sustainable ROIC is the single most important metric for quality investors, as it signals a strong competitive moat.
Debt Management: The filter requires a Debt-to-Free Cash Flow ratio of less than 5. Xylem’s ratio is a conservative 2.13. This means the company could theoretically pay off all its debt with just over two years of its current free cash flow, reflecting a very healthy balance sheet and low financial risk.
Profit Quality: The screen looks for an average profit quality (free cash flow as a percentage of net income) of at least 75% over the last five years. Xylem achieves a stellar 95.05% in this metric. This confirms that the vast majority of its reported earnings are being translated into actual, hard cash, a sign of genuine profitability rather than accounting adjustments.
Each of these criteria is central to the Caviar Cruise methodology. The combination of solid growth, exceptional capital efficiency, low leverage, and high-quality earnings provides a solid foundation for a long-term buy-and-hold investment.
General Fundamental Health and Valuation
A broader look at Xylem’s fundamentals, as detailed in the full fundamental analysis report, confirms its quality profile but also highlights some points for consideration. The company receives an overall fundamental rating of 6 out of 10.
Profitability (Rating: 7/10): This is a clear strength. Profitability ratios like Return on Assets, Return on Equity, and various profit margins are all above the average of its industry peers in the Machinery sector.
Dividend (Rating: 7/10): Xylem offers a dividend yield of 1.46%, which is attractive relative to its industry. It has a long and consistent history of paying and increasing its dividend, making it a candidate for dividend growth investors.
Health (Rating: 6/10): The balance sheet is generally solid, with a strong Altman-Z score and excellent solvency ratios. However, the report notes that its Return on Invested Capital (ROIC) is currently below its Weighted Average Cost of Capital (WACC), suggesting a period of value destruction. Additionally, the number of shares outstanding has increased over the past year and five years, which is a negative signal.
Growth (Rating: 5/10): Past growth is strong, but the future outlook shows a deceleration. While EPS is expected to grow at nearly 10% annually, the growth rate is projected to slow compared to the recent past. Revenue growth expectations are more modest at around 5% per year.
Valuation (Rating: 3/10): This is the weakest area. With a Price/Earnings (P/E) ratio of 21.67, the stock is not cheap. While it is slightly less expensive than its industry peers, the PEG ratio suggests the current price is not fully justified by the expected growth rate. Quality investors are often willing to pay a premium for quality, but this metric serves as a cautionary note that the market already has high expectations.
Analyst Views and Market Context
While the fundamental data is solid, it’s also useful to consider the broader market environment. The current long-term trend for the S&P 500 is neutral, but the short-term trend is positive. This mixed backdrop does not directly impact a company’s quality, but it does influence the general sentiment for risk assets like equities.
For a stock like Xylem, the primary risk is not business failure but its current valuation. The high P/E ratio leaves little room for error and makes the stock more vulnerable to market corrections. Should the company fail to meet its growth expectations, the share price could face significant headwinds. The deceleration in growth, combined with the premium price tag, means the investment thesis relies heavily on the company’s ability to sustain its competitive advantages and execute its strategy flawlessly.
The Bottom Line for Quality Investors
Xylem (XYL) passes the majority of strict quality investing filters with flying colors. Its extremely high ROIC, strong profit quality, and low debt levels are textbook examples of a durable business. The company’s essential role in the global water industry provides a long-term structural growth driver.
However, the premium valuation and the slight deceleration in expected growth mean it is not a "value" play. For a quality investor following a buy-and-hold strategy, Xylem appears to be a well-run company that could be a candidate for a long-term portfolio—provided the investor is comfortable paying a fair price for that quality.
Explore More Potential Quality Stocks
The Caviar Cruise screen is a valuable tool for identifying companies with these exact characteristics. If you are interested in finding other stocks that meet these strict quality criteria, you can run the screen for yourself.
Click here to see the latest results from the Caviar Cruise stock screener
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Past performance and screening results are not guarantees of future results. Always conduct your own due diligence before making any investment decisions.
Read full article here »